BRIEF-Viiv Healthcare says Aurobindo Pharma applies for FDA approval for HIV treatment
May 26, 2015 at 09:11 AM EDT
* Viiv Healthcare and CHAI collaboration delivers second milestone with first filing with the FDA of generic Dolutegravir for HIV treatment by Aurobindo Pharma
